Chasing other markets

While the US continues to contemplate the uses of medical cannabis, companies including Tilray (TLRY) are chasing other markets where regulators are more open to cannabis use compared to the US.

UK demand

Like other cannabis companies moving to increase their presence in the European market, Tilray is developing its UK market. Early on June 26, Tilray announced that it imported oral solutions for medical use into the UK. The oral solutions were produced in Canada at Tilray’s Good Manufacturing Practices certified Canadian facility.

Tilray expects the demand for medical cannabis in the United Kingdom to rise. Tilray is prepared for that market. In a press release, the company said, “As demand ramps up in the U.K., Tilray is well positioned to be a leading supplier of medical cannabis products.”

Tilray also stated that about six of its products have received regulatory approval to be sold to patients with prescriptions in the United Kingdom. The company plans to introduce more products in the market—CBD-dominant and THC-dominant products for patients.

Recently, we released our valuation analysis for cannabis companies. Tilray, Aurora Cannabis (ACB), and Canopy Growth (WEED) consistently traded higher than the peer median. Read Cannabis Sector: Are Investors Confident? to learn more.

Latest articles

WeWork is gearing up for an IPO. On Wednesday, the company made its IPO filing with the SEC public and expects to garner $3.5 billion from its IPO.

After FCC Chairman Ajit Pai recommended the approval of the T-Mobile–Sprint merger, Representative David Cicilline urged the FCC to allow public comment.

Cresco Labs (CRLBF) is set to report its Q2 earnings on August 21 after the market closes. The company's stock fell 5.3% yesterday.

Cannabis stocks mostly traded in positive territory today. Supreme Cannabis (FIRE) and Aurora Cannabis (ACB) rose about 9.5% and 5.5%, respectively.

NVIDIA (NVDA) stock soared 6% in today’s trading session as its Q2 earnings for fiscal 2020 beat estimates. However, its guidance missed estimates.

Nio Inc. (NIO) has disrupted the automotive space since 2014 but only made waves in the market since its IPO. Investors have suffered numerous setbacks.